Form 4: CVS Director Balser Acquires Shares

CVS Health Director Jeffrey R. Balser acquired 1,775 shares of common stock as part of his semi-annual retainer, increasing his beneficial ownership.

Summary

• Jeffrey R. Balser, a Director of CVS Health Corp, acquired 1,775 shares of CVS common stock.
• The transaction occurred on November 20, 2025, at a price of $76.04 per share.
• These shares were issued as payment for a semi-annual retainer, consistent with the Issuer's 2017 Incentive Compensation Plan.
• Following this acquisition, Mr. Balser beneficially owns 13,659 shares of CVS common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 6

Explanation: Slightly positive as a director is increasing their stake, even if it's for compensation. It indicates continued alignment of interests with shareholders.

Positives

• A Director, Jeffrey R. Balser, increased his beneficial ownership in CVS Health Corp by acquiring 1,775 shares.
• The acquisition was part of a pre-arranged compensation plan, indicating a structured approach to executive remuneration and alignment with shareholder interests.

Negatives

• No negative information is disclosed in this Form 4 filing.

Risks

• This Form 4 filing does not contain information regarding specific risks.

Future Outlook

This filing is an insider transaction report and does not contain forward-looking statements or guidance regarding the company's future outlook.

Industry Context

Insider transactions, particularly acquisitions by directors, are generally viewed by the market as a sign of confidence in the company's future prospects. This routine compensation-related acquisition by a director of a major healthcare company like CVS Health aligns with standard corporate governance practices for executive and director remuneration.

Comparison to Industry Standards

• This Form 4 filing details a routine acquisition of shares by a director as part of a compensation plan, which is a common practice across publicly traded companies.
• It does not provide specific financial results or project comparisons to industry benchmarks.
• The use of a Rule 10b5-1 plan for such transactions is also a standard practice to mitigate concerns about insider trading.

Corporate Governance

Related Party Transactions

• The acquisition of common stock by Director Jeffrey R. Balser as payment for a semi-annual retainer can be considered a related party transaction, as it involves compensation from the company to a member of its board. This is a standard and disclosed practice.

Stakeholder Impact

• Shareholders: May view the director's increased equity stake as a positive signal of confidence in the company's future performance and alignment of interests.

Next Steps

• This filing does not mention any specific future actions, events, or milestones.

Key Dates

Keywords

CVS Health, CVS, Jeffrey R. Balser, Director, Insider Transaction, Form 4, Stock Acquisition, Beneficial Ownership, 10b5-1 Plan, Incentive Compensation